pharma imports

Cancer patients in India are facing a critical shortage of life-saving chemotherapy drugs, Cisplatin and Carboplatin, disrupting treatment schedules. Hospitals report dwindling stocks, forcing patients to scramble for supplies. Doctors warn that prolonged unavailability of these essential medicines, with limited alternatives, could negatively impact patient outcomes and survival rates.

CRISIL Intelligence Report Warns That Export-Oriented And Energy-Intensive Clusters Stand The Most Exposed. Rising Input Costs, Shipping Disruptions Rising From The West Asia Conflict Threaten To Shrink Revenues Already Stressed Amid Weak Demand

Karnataka Examinations Authority has announced the KCET 2026 results. Over three lakh students appeared for the exam, with nearly 2.93 lakh declared eligible. Admissions to engineering, pharmacy, agriculture, and other professional courses will now proceed. Top engineering ranks were secured by students from Bengaluru and Mangaluru. Government college students also achieved notable ranks.

India’s pharmaceutical & software entrepreneurs show how economic strength matters in disrupted geopolitics. We should build such partnerships across the economy to navigate global headwinds

Geopolitical tensions in the Middle East are directly impacting household budgets, driving up prices for everyday essentials like cooking oil, milk, and bread. Soaring global crude oil prices and a weakening rupee are increasing import, fuel, and transportation costs, leading to a domino effect on consumer goods and even healthcare services.

German researchers are making waves with a cutting-edge 'Trojan horse' obesity drug that has eclipsed current frontrunners in trials with mice. The innovative formula decreases appetite and weight significantly while also enhancing blood sugar levels and insulin sensitivity. Utilizing hormone mimics for precise cellular targeting, this approach minimizes unwanted side effects and presents a multifaceted method for combating obesity.

Roche’s subcutaneous Tecentriq can be given in about seven minutes, cutting infusion time dramatically. But its impact in India will depend on patient selection, local post-marketing data, hospital readiness and whether a costly immunotherapy can become accessible beyond large private cancer centres

Lower-cost, latest-generation immunotherapies from China are a shot in the arm for Indian cancer patients who have been priced out of treatment by expensive drugs from western MNCs

Admissions are open for IISER Tirupati one-year Professional Master’s Programmes for 2026-2027 under Biological Data Science (BioDS) and Data Science and Artificial Intelligence (DS-AI). Offered in online mode, programmes target graduates and working professionals from science, technology and allied fields. Curriculum combines theoretical and applied learning with hands-on projects using real datasets. Eligibility includes specified undergraduate or postgraduate qualifications. aim to prepare industry-ready professionals for roles in data science, AI, biotechnology and life sciences sectors.

Country needs time to build up domestic capacities, till then reduce dependence on those ‘perfect’ imports

JPMorgan has shifted its stance on Indian equities to neutral, citing high valuations and geopolitical uncertainties. The brokerage warns of a potential 15% Nifty 50 decline in a worst-case scenario, impacting earnings due to energy supply risks. While the long-term outlook remains robust, near-term caution is advised, with other emerging markets potentially offering better opportunities.

Persistent Systems aims for $2 billion revenue by FY27. CEO Sandeep Kalra sees AI creating new opportunities, not just reducing costs. The company reported steady March quarter revenue. Kalra highlighted a platform-led approach and robust growth in top accounts. Persistent is investing in capabilities for long-term growth and adaptability.

What sets Qdenga apart is that it can be administered regardless of a prior infection. A phased rollout could take place as early as this year